News

Deal Announcements

KineMed Grabs $2 Million Venture Capital Equity

Monday, August 26, 2013 5:53:00 AM PDT | VentureDeal
   Emeryville, California  --  Drug discovery company KineMed has secured nearly $2 million in venture capital equity funding, according to an SEC regulatory filing.

KineMed is "employing its proprietary translational medicine technology to both identify active drug candidates pre-clinically and confirm their therapeutic activity and dose response in first-in-man studies."

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

KineMed is still seeking $6.4 million in additional financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1